Skip to main content

Management of Ventricular Arrhythmias: An Historical Perspective

  • Chapter
  • First Online:
Management of Cardiac Arrhythmias

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 1688 Accesses

Abstract

The treatment of ventricular arrhythmias has undergone vibrant change in the last 40 years, evolving from a largely intellectual exercise to an evidence-based, guideline-supported set of patient care strategies. This progress have been fueled by basic and clinical science and by the initial application of randomized clinical trials to the study of electrophysiology. Along the way, several strongly held beliefs were reconsidered, most notably the use of programmed stimulation or serial Holter montoring to guide pharmacologic therapy for ventricular tachycardia. Although antiarrhythmic drugs are still considered useful in reducing the frequency of recurrent VT episodes, our loss of confidence in guided drug therapy led to the development of device, surgical ablation, and catheter ablation therapies, which form the mainstay of treatment today.

A few hours before his death he told me … he did not feel any bodily ailments, and … without any sign of anything amiss, he passed away from this life.

… through failure of the artery that feeds the heart … which I found to be very parched and shrunk and withered.

– Leonardo DaVinci

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bayes de Luna A, Coumel P, Leclerq JF (1989) Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117:151–159

    Article  Google Scholar 

  2. Bigger JT Jr, Fleiss JL, Kleiger R et al (1984) The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69:250–258

    Article  PubMed  Google Scholar 

  3. Ruberman W, Weinblatt E, Goldberg JD et al (1981) Ventricular premature complexes and sudden death after myocardial infarction. Circulation 64:297–305

    Article  PubMed  CAS  Google Scholar 

  4. Lown B (1979) Sudden cardiac death – 1978. Circulation 60:1593–1599

    Article  PubMed  CAS  Google Scholar 

  5. The Beta Blocker Heart Attack Study Group (1981) The beta-blocker heart attack trial. JAMA 246:2073–2074

    Article  Google Scholar 

  6. Echt DS, Liebson PR, Mitchell LB et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 324:781–788

    Article  PubMed  CAS  Google Scholar 

  7. Wellens HJ, Schuilenburg RM, Durrer D (1972) Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation 46:216–226

    Article  PubMed  CAS  Google Scholar 

  8. Josephson M (2008) Clinical cardiac electrophysiology: techniques and interpretations, 4th edn. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  9. Horowitz LN, Josephson ME, Farshidi A et al (1978) Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation 58:986–997

    Article  PubMed  CAS  Google Scholar 

  10. Mason JW, Winkle RA (1978) Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 58:971–985

    Article  PubMed  CAS  Google Scholar 

  11. Waspe LE, Seinfeld D, Ferrick A et al (1985) Prediction of sudden death and spontaneous ventricular tachycardia in survivors of complicated myocardial infarction: value of the response to programmed stimulation using a maximum of three ventricular extrastimuli. J Am Coll Cardiol 5:1292–1301

    Article  PubMed  CAS  Google Scholar 

  12. Waller TJ, Kay HR, Spielman SR et al (1987) Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachycardia. J Am Coll Cardiol 10:83–89

    Article  PubMed  CAS  Google Scholar 

  13. Poll DS, Marchlinski FE, Buxton AE et al (1984) Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation 70:451–456

    Article  PubMed  CAS  Google Scholar 

  14. Investigators E (1989) The ESVEM trial. Electrophysiologic study versus electrocardiographic monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. Circulation 79:1354–1360

    Article  Google Scholar 

  15. Wellens HJ, Bar FW, Farre J et al (1980) Initiation and termination of ventricular tachycardia by supraventricular stimuli. Incidence and electrophysiologic determinants as observed during programmed stimulation of the heart. Am J Cardiol 46:576–582

    Article  PubMed  CAS  Google Scholar 

  16. Roy D, Waxman HL, Buxton AE et al (1982) Termination of ventricular tachycardia: role of tachycardia cycle length. Am J Cardiol 50:1346–1350

    Article  PubMed  CAS  Google Scholar 

  17. Josephson ME, Horowitz LN, Farshidi A et al (1978) Recurrent sustained ventricular tachycardia. 2. Endocardial mapping. Circulation 57:440–447

    Article  PubMed  CAS  Google Scholar 

  18. Josephson ME, Horowitz LN, Spielman SR et al (1980) Comparison of endocardial catheter mapping with intraoperative mapping of ventricular tachycardia. Circulation 61:395–404

    Article  PubMed  CAS  Google Scholar 

  19. Cassidy DM, Vassallo JA, Miller JM et al (1986) Endocardial catheter mapping in patients in sinus rhythm: relationship to underlying heart disease and ventricular arrhythmias. Circulation 73:645–652

    Article  PubMed  CAS  Google Scholar 

  20. Kienzle MG, Miller J, Falcone RA et al (1984) Intraoperative endocardial mapping during sinus rhythm: relationship to site of origin of ventricular tachycardia. Circulation 70:957–965

    Article  PubMed  CAS  Google Scholar 

  21. Guiraudon G, Fontaine G, Frank R et al (1978) Encircling endocardial ventriculotomy: a new surgical treatment for life-threatening ventricular tachycardias resistant to medical treatment following myocardial infarction. Ann Thoracic Surg 26:438–444

    Article  CAS  Google Scholar 

  22. Mirowski M, Mower MM, Reid PR et al (1982) The automatic implantable defibrillator. New modality for treatment of life-threatening ventricular arrhythmias. Pacing Clin Electrophysiol 5:384–401

    Article  PubMed  CAS  Google Scholar 

  23. AVID (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The antiarrhythmics versus implantable defibrillators (AVID) investigators. N Engl J Med 337:1576–1583

    Article  Google Scholar 

  24. Moss AJ, Zareba W, Hall WJ (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 348:1882–1890

    Google Scholar 

  25. Buxton AE, Lee KL, DiCarlo L et al (2000) Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter unsustained tachycardia trial investigators. N Engl J Med 342:1937–1945

    Article  PubMed  CAS  Google Scholar 

  26. Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  27. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. 352:225–237

    PubMed  CAS  Google Scholar 

  28. Kadish A, Quigg R, Schaechter A et al (2000) Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol 23:338–343

    Article  PubMed  CAS  Google Scholar 

  29. Strickberger SA, Hummel JD, Bartlett TG et al (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia AMIOVIRT. J Am Coll Cardiol 41:1707–1712

    Article  PubMed  Google Scholar 

  30. Tung R, Zimetbaum P, Josephson ME (2008) A critical appraisal of implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death. J Am Coll Cardiol 52:1111–1121

    Article  PubMed  Google Scholar 

  31. Almendral JM, Stamato NJ, Rosenthal ME et al (1986) Resetting response patterns during sustained ventricular tachycardia: relationship to the excitable gap. Circulation 74:722–730

    Article  PubMed  CAS  Google Scholar 

  32. Almendral JM, Gottlieb CD, Rosenthal ME et al (1988) Entrainment of ventricular tachycardia: explanation for surface electrocardiographic phenomena by analysis of electrograms recorded within the tachycardia circuit. Circulation 77:569–580

    Article  PubMed  CAS  Google Scholar 

  33. Morady F, Kadish AH, Rosenheck S et al (1991) Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol 17:678–689

    Article  PubMed  CAS  Google Scholar 

  34. Stevenson W, Khan H, Sager P et al (1993) Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 88:1647–1670

    Article  PubMed  CAS  Google Scholar 

  35. Marchlinski FE, Callans DJ, Gottlieb CD et al (2000) Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 101:1288–1296

    Article  PubMed  CAS  Google Scholar 

  36. Arenal A, del Castillo S, Gonzalez-Torrecilla E et al (2004) Tachycardia related channel in the scar tissue in patients with sustained monomorphic ventricular tachycardias. Influence of the voltage scar definition. Circulation 110:2568–2574

    Article  PubMed  Google Scholar 

  37. Reddy VY, Reynolds MR, Neuzil P et al (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357:2657–2665

    Article  PubMed  CAS  Google Scholar 

  38. Horowitz LN, Josephson ME, Kastor JA (1980) Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia. Prog Cardiovasc Dis 23:81–98

    Article  PubMed  CAS  Google Scholar 

  39. Kastor JA, Horowitz LN, Harken AH et al (1981) Clinical electrophysiology of ventricular tachycardia. N Engl J Med 304:1004

    Article  PubMed  CAS  Google Scholar 

  40. Stevenson WG, Wilber DJ, Natale A, et al (2008) Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation 118:2773–2782

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Callans, D.J., Josephson, M.E. (2011). Management of Ventricular Arrhythmias: An Historical Perspective. In: Yan, GX., Kowey, P. (eds) Management of Cardiac Arrhythmias. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-161-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-161-5_1

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-160-8

  • Online ISBN: 978-1-60761-161-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics